Fox Chase Cancer Center News

October 25, 2021

Study Finds Low Risk of Toxicity in Prostate Cancer Patients Treated With Hypofractionated Radiation Therapy

PHILADELPHIA (October 25, 2021)—A multi-institutional retrospective analysis conducted by researchers at Fox Chase Cancer Center has found that early stage prostate cancer patients treated with moderately hypofractionated intensity-modulated radiation therapy or proton beam radiation therapy had low risk of serious late genitourinary and gastrointestinal complications.

October 24, 2021

Fox Chase Researchers Find Pulsed Low-Dose Rate Radiotherapy Shows Improvement Over Standard Twice-Daily Radiation

PHILADELPHIA (October 24, 2021)—In a recent retrospective study, researchers at Fox Chase Cancer Center found anorectal cancer patients reirradiated with pulsed low-dose-rate radiotherapy had reduced toxicity and improved outcomes when compared with patients treated with twice-daily radiotherapy.

October 19, 2021

Fox Chase Researcher Edna Cukierman Appointed Senior Editor on New Journal

PHILADELPHIA (October 19, 2021)—Fox Chase Cancer Center’s Edna “Eti” Cukierman, PhD, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been named a senior editor for Cancer Research Communications, a new online journal.  

October 15, 2021

Researchers at Fox Chase Find Crucial Role for Common Brain Tumor Protein

PHILADELPHIA (October 15, 2021)—Recent findings from a study conducted at Fox Chase Cancer Center could help pave the way for more effective treatment of aggressive brain tumors, researchers say.

October 15, 2021

Pancreatic Cancer Cure Foundation to Present Donation to Fund Research at Fox Chase Cancer Center

PHILADELPHIA (October 15, 2021)—The Pancreatic Cancer Cure Foundation will present a donation of $28,500 to the lab of Edna “Eti” Cukierman, PhD, a co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, on Monday, October 18, to fund further research into detecting and treating pancreatic cancer

October 14, 2021

Fox Chase Researcher Alfonso Bellacosa to Be Honored at First Annual Italian-American Medical Awards

PHILADELPHIA, (October 14, 2021)—Fox Chase Cancer Center researcher Alfonso Bellacosa, MD, PhD, was recently named a recipient of the first ever 2021 Mid-Atlantic Italian American Medical Awards.

October 14, 2021

Fox Chase’s Cristina Uribe-Alvarez Receives Grant to Study RAC1 Mutations in Melanoma

PHILADELPHIA (October 14, 2021)—Cristina Uribe-Alvarez, PhD, a postdoctoral associate in the lab of Jonathan Chernoff, MD, PhD, at Fox Chase Cancer Center recently received a $75,000 one-year grant from the F.M. Kirby Foundation to continue her study on RAC1 mutations in melanoma.

October 14, 2021

Study Provides New Insights Into DNA Replication Timing Through Evaluating the Dynamics of Epigenetic States

PHILADELPHIA (October 14, 2021)—A recent study by Fox Chase Cancer Center scientists provides new insight into the mechanism that controls DNA replication timing (RT), a process that is controlled during development and dysfunctional in diseases such as cancer.


Connect with Fox Chase